Article
LncRNA POU6F2-AS2 contributes to malignant phenotypes and paclitaxel resistance by promoting SKP2 expression in stomach adenocarcinoma.
Journal of chemotherapy (Florence, Italy) - 1 Nov 2023
Jin Yanzhao, Cao Jiaqing, Cheng Hua, Hu Xiaoyun
Abstract excerpt
This study aimed to investigate the role and mechanism of POU6F2-AS2 in the development of gastric cancer. POU6F2-AS2 expression was considerably higher in clinical stomach adenocarcinoma (STAD) tissues and gastric cancer cell lines (MKN-28 and MGC-803) than in neighbouring normal tissues and gastric mucosa epithelial cells (GES-1). POU6F2-AS2 overexpression resulted in a low overall survival probability,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
